181.53MMarket Cap-17.05P/E (TTM)
14.470High13.250Low68.53KVolume13.500Open13.110Pre Close946.90KTurnover1.16%Turnover RatioLossP/E (Static)13.14MShares21.44052wk High36.44P/B81.76MFloat Cap8.00052wk Low--Dividend TTM5.92MShs Float158.070Historical High--Div YieldTTM9.31%Amplitude3.262Historical Low13.816Avg Price1Lot Size
Greenwich LifeSciences Stock Forum
3 MINUTES AGO, 6:00 AM EST
VIA GLOBENEWSWIRE
STAFFORD, Texas, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced its partnership with clinical sites in Italy.
The Compan...
monitor for volume to buy more.
$Silvergate Capital (SI.US)$ $Ardelyx (ARDX.US)$ $Greenwich LifeSciences (GLSI.US)$ $Atlis Motor (AMV.US)$ $Bed Bath & Beyond Inc (BBBY.US)$
$Bed Bath & Beyond Inc (BBBY.US)$ $Greenwich LifeSciences (GLSI.US)$ $Ardelyx (ARDX.US)$ $Silvergate Capital (SI.US)$
No comment yet